US Patent Issued to Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences on June 17 for "Use of berbamine dihydrochloride in preparation of Ebola virus inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,754, issued on June 17, was assigned to Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (Beijing).

"Use of berbamine dihydrochloride in preparation of Ebola virus inhibitor" was invented by Shan Cen (Beijing), Quanjie Li (Beijing), Dongrong Yi (Beijing), Yi Shi (Beijing), Han Wang (Beijing) and Jinming Zhou (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capabili...